Scleritis
Definition/diagnostic criteria Scleritis is a rare, severe inflammation of the sclera (the white part of the eyeball). It is a potentially sight-threatening condition and can be bilateral in about 50% of cases.
Epidemiology
- Incidence: Approximately 3.4 per 100,000 per annum.
- Age group: Predominantly affects individuals in the middle age group (40-60 years).
- Gender prevalence: More common in females, with a male to female ratio of 2:3.
- Associated conditions: Around 30-40% of cases are linked with autoimmune diseases.
Diagnosis
Clinical features:
- Symptoms: Include moderate or severe eye pain, which can extend to the brow or jaw, sleep disturbance, tenderness of the globe, photophobia, epiphora (watery eyes) and visual loss.
- Types: Can involve the anterior or posterior sclera, or both.
– Anterior scleritis accounts for 90% of cases and is subdivided into non-necrotising (most common) and necrotising forms.
– Posterior scleritis is less common but can present with more severe symptoms.
Investigations: Investigations for systemic associations and imaging to investigate posterior segment involvement are crucial for a comprehensive diagnosis. The type of scleritis (e.g., necrotising, non-necrotising) guides the approach to further investigations.
Treatment
- Initial management: Systemic analgesia is recommended for pain management.
- Referral: Necrotising anterior scleritis and posterior scleritis require emergency referral, while non-necrotising anterior scleritis calls for an urgent referral to an ophthalmologist.
- Ophthalmologist management: May include systemic NSAIDs, topical steroids, systemic immunosuppression (corticosteroids, other immunosuppressant drugs, biologics like TNF alpha inhibitors), and imaging for posterior segment involvement.
Prognosis The prognosis of scleritis varies depending on the type and severity. Necrotising scleritis, particularly, can lead to significant visual impairment.
Further reading
- The College of Optometrists. Scleritis. 2022.
- NICE CKS. Red eye. 2021.
- ChatGPT has assisted in the creation of this content which has been then thoroughly reviewed by our GP advisors to ensure its timeliness and reliability.